ACET
Price
$2.47
Change
+$0.03 (+1.23%)
Updated
Feb 23, 6:59 PM EST
17 days until earnings call
DVAX
Price
$12.75
Change
+$0.31 (+2.49%)
Updated
Feb 23, 6:59 PM EST
67 days until earnings call
Ad is loading...

Compare trend and price ACET vs DVAX

Header iconACET vs DVAX Comparison
Open Charts ACET vs DVAXBanner chart's image
Adicet Bio
Price$2.47
Change+$0.03 (+1.23%)
Volume$576.99K
CapitalizationN/A
Dynavax Technologies
Price$12.75
Change+$0.31 (+2.49%)
Volume$1.77M
CapitalizationN/A
View a ticker or compare two or three
ACET vs DVAX Comparison Chart

Loading...

ACETDaily Signal changed days agoGain/Loss if shorted
 
Show more...
DVAXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ACET vs. DVAX commentary
Feb 26, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACET is a Sell and DVAX is a Hold.

COMPARISON
Comparison
Feb 26, 2024
Stock price -- (ACET: $2.47 vs. DVAX: $12.75)
Brand notoriety: ACET and DVAX are both not notable
ACET represents the Biotechnology, while DVAX is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ACET: 59% vs. DVAX: 165%
Market capitalization -- ACET: $202.66M vs. DVAX: $1.67B
ACET [@Biotechnology] is valued at $202.66M. DVAX’s [@Pharmaceuticals: Other] market capitalization is $1.67B. The market cap for tickers in the [@Biotechnology] industry ranges from $550.21B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $90.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.58B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACET’s FA Score shows that 1 FA rating(s) are green whileDVAX’s FA Score has 1 green FA rating(s).

  • ACET’s FA Score: 1 green, 4 red.
  • DVAX’s FA Score: 1 green, 4 red.
According to our system of comparison, ACET is a better buy in the long-term than DVAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACET’s TA Score shows that 4 TA indicator(s) are bullish while DVAX’s TA Score has 5 bullish TA indicator(s).

  • ACET’s TA Score: 4 bullish, 5 bearish.
  • DVAX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, DVAX is a better buy in the short-term than ACET.

Price Growth

ACET (@Biotechnology) experienced а -15.99% price change this week, while DVAX (@Pharmaceuticals: Other) price change was +2.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.03%. For the same industry, the average monthly price growth was +18.51%, and the average quarterly price growth was +38.88%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.03%. For the same industry, the average monthly price growth was +1.14%, and the average quarterly price growth was +52.04%.

Reported Earning Dates

ACET is expected to report earnings on May 08, 2024.

DVAX is expected to report earnings on May 02, 2024.

Industries' Descriptions

@Biotechnology (+2.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Pharmaceuticals: Other (+0.03% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
A.I.dvisor published
a Summary for ACET with price predictions.
OPEN
A.I.dvisor published
a Summary for DVAX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
DVAX($1.67B) has a higher market cap than ACET($203M). DVAX has higher P/E ratio than ACET: DVAX (31.10) vs ACET (6.06). ACET YTD gains are higher at: 30.688 vs. DVAX (-8.798). DVAX has higher annual earnings (EBITDA): 76.1M vs. ACET (-137.52M). DVAX has more cash in the bank: 720M vs. ACET (183M). ACET has less debt than DVAX: ACET (21.8M) vs DVAX (257M). DVAX has higher revenues than ACET: DVAX (361M) vs ACET (0).
ACETDVAXACET / DVAX
Capitalization203M1.67B12%
EBITDA-137.52M76.1M-181%
Gain YTD30.688-8.798-349%
P/E Ratio6.0631.1019%
Revenue0361M-
Total Cash183M720M25%
Total Debt21.8M257M8%
FUNDAMENTALS RATINGS
ACET vs DVAX: Fundamental Ratings
ACET
DVAX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
66
Overvalued
PROFIT vs RISK RATING
1..100
10081
SMR RATING
1..100
9767
PRICE GROWTH RATING
1..100
3761
P/E GROWTH RATING
1..100
253
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACET's Valuation (41) in the Medical Distributors industry is in the same range as DVAX (66) in the Biotechnology industry. This means that ACET’s stock grew similarly to DVAX’s over the last 12 months.

DVAX's Profit vs Risk Rating (81) in the Biotechnology industry is in the same range as ACET (100) in the Medical Distributors industry. This means that DVAX’s stock grew similarly to ACET’s over the last 12 months.

DVAX's SMR Rating (67) in the Biotechnology industry is in the same range as ACET (97) in the Medical Distributors industry. This means that DVAX’s stock grew similarly to ACET’s over the last 12 months.

ACET's Price Growth Rating (37) in the Medical Distributors industry is in the same range as DVAX (61) in the Biotechnology industry. This means that ACET’s stock grew similarly to DVAX’s over the last 12 months.

DVAX's P/E Growth Rating (3) in the Biotechnology industry is in the same range as ACET (25) in the Medical Distributors industry. This means that DVAX’s stock grew similarly to ACET’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACETDVAX
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
75%
Momentum
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
80%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
77%
Advances
ODDS (%)
Bullish Trend 11 days ago
84%
Bullish Trend 11 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 6 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
78%
Aroon
ODDS (%)
Bullish Trend 5 days ago
79%
Bearish Trend 3 days ago
78%
View a ticker or compare two or three
Ad is loading...
ACETDaily Signal changed days agoGain/Loss if shorted
 
Show more...
DVAXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FSVRX10.860.08
+0.74%
Clifford Capital Fcs Sm Cp Val Inv
JFNSX71.320.41
+0.58%
Janus Henderson Global Life Sciences S
HEOSX15.390.06
+0.39%
Hartford Climate Opportunities R4
TSMNX14.260.04
+0.28%
TIAA-CREF Quant Sm/Md-Cp Eq Advisor
MFUZX8.790.01
+0.11%
MassMutual Fundamental Value I

ACET and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACET has been loosely correlated with OGI. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ACET jumps, then OGI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACET
1D Price
Change %
ACET100%
+1.23%
OGI - ACET
41%
Loosely correlated
+2.02%
DVAX - ACET
39%
Loosely correlated
+2.49%
TERN - ACET
39%
Loosely correlated
+2.78%
DCPH - ACET
39%
Loosely correlated
+1.97%
NKTX - ACET
37%
Loosely correlated
+1.05%
More

DVAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, DVAX has been loosely correlated with ACET. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if DVAX jumps, then ACET could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DVAX
1D Price
Change %
DVAX100%
+2.49%
ACET - DVAX
39%
Loosely correlated
+1.23%
SNDL - DVAX
35%
Loosely correlated
N/A
SIGA - DVAX
32%
Poorly correlated
+3.50%
ELAN - DVAX
32%
Poorly correlated
+1.36%
IRWD - DVAX
30%
Poorly correlated
+1.41%
More